loadpatents
name:-0.021575927734375
name:-0.016578197479248
name:-0.007580041885376
Flotte; Terence Patent Filings

Flotte; Terence

Patent Applications and Registrations

Patent applications and USPTO patent grants for Flotte; Terence.The latest application filed is for "aav capsid chimeric antigen receptors and uses thereof".

Company Profile
7.17.21
  • Flotte; Terence - Holden MA
  • Flotte; Terence - Gainesville FL
  • Flotte; Terence - Baltimore MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Aav Capsid Chimeric Antigen Receptors And Uses Thereof
App 20220220170 - Keeler-Klunk; Allison ;   et al.
2022-07-14
Raav-based Compositions And Methods
App 20220204974 - Flotte; Terence ;   et al.
2022-06-30
RAAV-based compositions and methods
Grant 11,254,939 - Flotte , et al. February 22, 2
2022-02-22
Perfusion-based Delivery Of Recombinant Aav Vectors For Expression Of Secreted Proteins
App 20210393805 - Gruntman; Alisha ;   et al.
2021-12-23
Campaign-ready Series Of Recombinant Adeno-associated Virus (raav) Complementing Plasmids
App 20210047650 - Flotte; Terence ;   et al.
2021-02-18
Novel Aav's And Uses Thereof
App 20200377554 - Gao; Guangping ;   et al.
2020-12-03
Raav-based Compositions And Methods
App 20200339988 - Flotte; Terence ;   et al.
2020-10-29
AAV's and uses thereof
Grant 10,689,420 - Gao , et al.
2020-06-23
RAAV-based compositions and methods
Grant 10,597,656 - Flotte , et al.
2020-03-24
Recombinant Aav Variants And Uses Thereof
App 20200024617 - Gao; Guangping ;   et al.
2020-01-23
Recombinant AAV variants and uses thereof
Grant 10,480,011 - Gao , et al. Nov
2019-11-19
Raav-based Compositions And Methods
App 20190211327 - Flotte; Terence ;   et al.
2019-07-11
Novel Aav's And Uses Thereof
App 20180362592 - Gao; Guangping ;   et al.
2018-12-20
Raav-based Compositions And Methods
App 20180265865 - Flotte; Terence ;   et al.
2018-09-20
rAAV-based compositions and methods
Grant 10,077,452 - Flotte , et al. September 18, 2
2018-09-18
AAV's and uses thereof
Grant 10,035,825 - Gao , et al. July 31, 2
2018-07-31
RAAV-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
Grant 9,885,057 - Flotte , et al. February 6, 2
2018-02-06
Recombinant Aav Variants And Uses Thereof
App 20180023094 - Gao; Guangping ;   et al.
2018-01-25
Raav-based Compositions And Methods For Treating Alpha-1 Anti-trypsin Deficiencies
App 20170369874 - Flotte; Terence ;   et al.
2017-12-28
Raav-based Compositions And Methods For Treating Alpha-1 Anti-trypsin Deficiencies
App 20170159071 - Flotte; Terence ;   et al.
2017-06-08
Raav-based Compositions And Methods For Treating Alpha-1 Anti-trypsin Deficiencies
App 20160326524 - Flotte; Terence ;   et al.
2016-11-10
Novel Aav's And Uses Thereof
App 20160222067 - Gao; Guangping ;   et al.
2016-08-04
Raav-based Compositions And Methods For Treating Alpha-1 Anti-trypsin Deficiencies
App 20160186211 - Flotte; Terence ;   et al.
2016-06-30
AAV's and uses thereof
Grant 9,284,357 - Gao , et al. March 15, 2
2016-03-15
RAAV-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
Grant 9,226,976 - Flotte , et al. January 5, 2
2016-01-05
Novel Aav's And Uses Thereof
App 20140296486 - Gao; Guangping ;   et al.
2014-10-02
AAV's and uses thereof
Grant 8,734,809 - Gao , et al. May 27, 2
2014-05-27
Raav-based Compositions And Methods For Treating Alpha-1 Anti-trypsin Deficiencies
App 20140142161 - Flotte; Terence ;   et al.
2014-05-22
Novel Aav's And Uses Thereof
App 20120137379 - Gao; Guangping ;   et al.
2012-05-31
Modified adeno-associated virus vector capable of expression from a novel promoter
Grant 6,165,781 - Carter , et al. December 26, 2
2000-12-26
Amino-terminally truncated cystic fibrosis transmembrane conductance regulator
Grant 5,990,279 - Carter , et al. November 23, 1
1999-11-23
Modified adeno-associated virus vector capable of expression from a novel promoter
Grant 5,989,540 - Carter , et al. November 23, 1
1999-11-23
Modified adeno-associated virus vector capable of expression from a novel promoter
Grant 5,866,696 - Carter , et al. February 2, 1
1999-02-02
Modified adeno-associated virus vector capable of expression from a novel promoter
Grant 5,587,308 - Carter , et al. December 24, 1
1996-12-24
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed